{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:11:37Z","timestamp":1771654297302,"version":"3.50.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/bf03346668","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:50:16Z","timestamp":1396043416000},"page":"671-682","source":"Crossref","is-referenced-by-count":48,"title":["Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)"],"prefix":"10.1007","volume":"33","author":[{"given":"A.","family":"Peri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Festuccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"issue":"3","key":"BF03346668_CR1","first-page":"1","volume":"2","author":"D O\u2019Donoghue","year":"2009","unstructured":"O\u2019Donoghue D, Trehan. SIADH and hyponatremia: foreword. NDT Plus 2009, 2 (Suppl 3): 1\u20134.","journal-title":"NDT Plus"},{"key":"BF03346668_CR2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1530\/EJE-09-1063","volume":"162","author":"M Hannon","year":"2010","unstructured":"Hannon M, Thompson C. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol 2010, 162: S5\u201312.","journal-title":"Eur J Endocrinol"},{"key":"BF03346668_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3810\/pgm.2000.5.1.1068","volume":"107","author":"PJ Fall","year":"2000","unstructured":"Fall PJ. Hyponatremia and hypernatremia. A systematic approach to causes and their correction. Postgrad Med 2000, 107: 75\u201382.","journal-title":"Postgrad Med"},{"key":"BF03346668_CR4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ki.1986.134","volume":"29","author":"RJ Anderson","year":"1986","unstructured":"Anderson RJ. Hospital-associated hyponatremia. Kidney Int 1986, 29: 1237\u201347.","journal-title":"Kidney Int"},{"key":"BF03346668_CR5","doi-asserted-by":"crossref","first-page":"71e1","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006, 119: 71e1\u20138.","journal-title":"Am J Med"},{"key":"BF03346668_CR6","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1111\/j.1540-8167.2009.01500.x","volume":"20","author":"RA Rabenou","year":"2009","unstructured":"Rabenou RA. Hyponatremia: disorder of water, not salt. J Cardiovasc Electrophysiol 2009, 20: E66.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"BF03346668_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.semnephrol.2009.03.005","volume":"29","author":"G Decaux","year":"2009","unstructured":"Decaux G. The syndrome of inappropiate secretion of antidiuretic hormone (SIADH). Semin Nephrol 2009, 29: 239\u201356.","journal-title":"Semin Nephrol"},{"key":"BF03346668_CR8","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","volume":"356","author":"DH Ellison","year":"2007","unstructured":"Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007, 356: 2064\u201372.","journal-title":"N Engl J Med"},{"key":"BF03346668_CR9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","volume":"342","author":"HJ Adrogu\u00e9","year":"2000","unstructured":"Adrogu\u00e9 HJ, Madias NE. Hyponatremia. N Engl J Med 2000, 342: 1493\u20139.","journal-title":"N Engl J Med"},{"key":"BF03346668_CR10","unstructured":"Caldwell HK, Young WS III. Oxytocin and vasopressin: genetics and behavioral implications. In: Lajtha A, Lim R. (eds.) Handbook of Neurochemistry and Molecular Neurobiology: Neuroactive Proteins and Peptides (3rd ed.). Barlin: Springer, 2006. 573\u2013607."},{"key":"BF03346668_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2010.03.004","volume":"458","author":"MR Elphick","year":"2010","unstructured":"Elphick MR. NG peptides: a novel family of neurophysin-associated neuropeptides. Gene 2010, 458: 20\u20136.","journal-title":"Gene"},{"key":"BF03346668_CR12","first-page":"325","volume":"65","author":"HP Peters","year":"2007","unstructured":"Peters HP, Robben JH, Deen PM, Wetzels JF. Water in healh and disease: new aspects of disturbances in water metabolism. Neth J Med 2007, 65: 325\u201332.","journal-title":"Neth J Med"},{"key":"BF03346668_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bpa.2008.03.003","volume":"22","author":"MO Maybauer","year":"2008","unstructured":"Maybauer MO, Maubauer DM, Enkhbaatar P, Traber DL. Physiology of vasopressin receptor. Best Pract Res Clin Anaesthesiol 2008, 22: 253\u201363.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"BF03346668_CR14","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1210\/en.2005-0868","volume":"146","author":"G Valenti","year":"2005","unstructured":"Valenti G, Procino G, Tamma G, Carmosino M, Svelto M. Mini-review: aquaporin 2 trafficking. Endocrinology 2005, 146: 5063\u201370.","journal-title":"Endocrinology"},{"key":"BF03346668_CR15","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1152\/ajpcell.2000.278.1.C13","volume":"278","author":"AS Verkman","year":"2000","unstructured":"Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol 2000, 278: F13\u201328.","journal-title":"Am J Physiol"},{"key":"BF03346668_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-540-79885-9_6","volume":"190","author":"PI Nedvetsky","year":"2009","unstructured":"Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E. Regulation of aquaporin-2 trafficking. Handb Exp Pharmacol 2009, 190: 133\u201357.","journal-title":"Handb Exp Pharmacol"},{"key":"BF03346668_CR17","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1152\/ajpcell.2000.278.1.C13","volume":"278","author":"AS Verkman","year":"2000","unstructured":"Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol 2000, 278: F13\u201328.","journal-title":"Am J Physiol"},{"key":"BF03346668_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1358\/dnp.2007.20.7.1138161","volume":"20","author":"RW Schrier","year":"2007","unstructured":"Schrier RW. Aquaporin-related disorders of water homeostasis. Drug News Perspect 2007, 20: 447\u201353.","journal-title":"Drug News Perspect"},{"key":"BF03346668_CR19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneph.2009.231","volume":"6","author":"Y Noda","year":"2010","unstructured":"Noda Y, Sohara E, Ohta E, Sasaki S. Aquaporins in kidney pathophysiology. Nat Rev Nephrol 2010, 6: 168\u201378.","journal-title":"Nat Rev Nephrol"},{"key":"BF03346668_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2008.12.057","volume":"1258","author":"T Ohbuchi","year":"2009","unstructured":"Ohbuchi T, Yokoyama T, Saito T, et al. Brain-derived neutrotrophic factor inhibits spontaneous inhibitory postsynaptic currents in the rat supraoptic nucleus. Brain Res 2009, 1258: 34\u201342.","journal-title":"Brain Res"},{"key":"BF03346668_CR21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.2006030240","volume":"17","author":"RW Schrier","year":"2006","unstructured":"Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 2006, 17: 1820\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"BF03346668_CR22","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjmed.2006.05.006","volume":"119","author":"GL Robertson","year":"2006","unstructured":"Robertson GL. Regulation of arginine vasopressin in the syndrome inappropriate antediuresis. Am J Med 2006, 119 (Suppl 1): S36\u201342.","journal-title":"Am J Med"},{"key":"BF03346668_CR23","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"RW Schrier","year":"2006","unstructured":"Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006, 119: S47\u201353.","journal-title":"Am J Med"},{"key":"BF03346668_CR24","first-page":"E540","volume":"247","author":"JG Verbalis","year":"1984","unstructured":"Verbalis JG. An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat. Am J Physiol 1984, 247: E540\u201353.","journal-title":"Am J Physiol"},{"key":"BF03346668_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000216184","volume":"16","author":"A Papadimitriou","year":"2009","unstructured":"Papadimitriou A, Priftis KN. Regulation of hypotalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009, 16: 265\u201371.","journal-title":"Neuroimmunomodulation"},{"key":"BF03346668_CR26","first-page":"170","volume":"82","author":"T Kahn","year":"2003","unstructured":"Kahn T. Reset osmostat and salt and water retention in the course of severe hyponatremia. Medicine (Baltimora) 2003, 82: 170\u20136.","journal-title":"Medicine (Baltimora)"},{"key":"BF03346668_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)62362-6","volume":"91","author":"R Gerstberger","year":"1992","unstructured":"Gerstberger R, M\u00fcller AR, Simon-Oppermann C. Functional hypothalamic angiotensin II and catecholamine receptor systems inside and outside the blood-brain barrier. Prog Brain Res 1992, 91: 423\u201333.","journal-title":"Prog Brain Res"},{"key":"BF03346668_CR28","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","volume":"352","author":"BJ Feldman","year":"2005","unstructured":"Feldman BJ, Rosenthal SM, Vargas GA. Nephrogenic syndrome of inappropriate antidiuresis. New Engl J Med 2005, 352: 1884\u201390.","journal-title":"New Engl J Med"},{"key":"BF03346668_CR29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2006090987","volume":"18","author":"G Decaux","year":"2007","unstructured":"Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 2007, 18: 606\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346668_CR30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0002-9343(83)90462-X","volume":"75","author":"DS Kramer","year":"1983","unstructured":"Kramer DS, Drake ME Jr. Acute psychosis, polydipsia, and inappropriate secretion of antidiuretic hormone. Am J Med 1983, 75: 712\u20134.","journal-title":"Am J Med"},{"key":"BF03346668_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198802183180702","volume":"318","author":"MB Goldman","year":"1988","unstructured":"Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psycotic patients with polyuria and hyponatremia. N Engl J Med 1988, 318: 397\u2013403.","journal-title":"N Engl J Med"},{"key":"BF03346668_CR32","first-page":"280","volume":"33","author":"Z Samaan","year":"2008","unstructured":"Samaan Z, Macqueen G. Subacute alteration in level of consciousness in a woman with psychotic depression. J Psychiatry Neurosci 2008, 33: 280.","journal-title":"J Psychiatry Neurosci"},{"key":"BF03346668_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11920-007-0025-7","volume":"9","author":"B Dundas","year":"2007","unstructured":"Dundas B, Harris M, Narasimhan M. Psychogenic polydipsia review: etiology, differential and treatment. Curr Psychiatry Rep 2007, 9: 236\u201341.","journal-title":"Curr Psychiatry Rep"},{"key":"BF03346668_CR34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(197909)44:3<896::AID-CNCR2820440316>3.0.CO;2-9","volume":"44","author":"PJ Harlow","year":"1979","unstructured":"Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 1979, 44: 896\u20138.","journal-title":"Cancer"},{"key":"BF03346668_CR35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archinte.1985.00360030196034","volume":"145","author":"RB Bressler","year":"1985","unstructured":"Bressler RB, Huston DP. Water intoxication following moderate dose intravenous cyclophosphamide. Arch Intern Med 1985, 145: 548\u20139.","journal-title":"Arch Intern Med"},{"key":"BF03346668_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0609.1996.tb00724.x","volume":"56","author":"E Bjorck","year":"1996","unstructured":"Bjorck E, Samuelsson J. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after treatment with cyclophosphamide, alfa-interferon and betamethasone in in patient with multiple myeloma. Eur J Haematol 1996, 56: 323\u20135.","journal-title":"Eur J Haematol"},{"key":"BF03346668_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/ken402","volume":"48","author":"NV Jayachandran","year":"2009","unstructured":"Jayachandran NV, Chandrasekhara PK, Thomas J, Agrawal S, Narsimulu G. Cyclophosphamide-associated complication: we need to be aware of SIADH and central pontine myelinolysis. Rheumatology 2009, 48: 89\u201390.","journal-title":"Rheumatology"},{"key":"BF03346668_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11096-009-9353-5","volume":"32","author":"T Koide","year":"2010","unstructured":"Koide T, Wakabayashi T, Matsuda T, Horiike S, Watanabe K. Hyponatremia associated with paroxetine induced by sodium-restricted diet and hypotonic saline. Pharm World Sci 2010, 32: 19\u201321.","journal-title":"Pharm World Sci"},{"key":"BF03346668_CR39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","volume":"33","author":"D Meulendijks","year":"2010","unstructured":"Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, Egberts TC. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010, 33: 101\u201314.","journal-title":"Drug Saf"},{"key":"BF03346668_CR40","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1742-1241.2009.02103.x","volume":"64","author":"P Reddy","year":"2009","unstructured":"Reddy P, Mooradian AD. Diagnosis and management of hyponatremia in hospitalised patients. Int J Clin Pract 2009, 64: 1494\u2013508.","journal-title":"Int J Clin Pract"},{"key":"BF03346668_CR41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.6.5.468","volume":"6","author":"T Kadowaki","year":"1983","unstructured":"Kadowaki T, Hagura R, Kajinuma H, Kuzuya N, Yoshida S. Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care 1983, 6: 468\u201371.","journal-title":"Diabetes Care"},{"key":"BF03346668_CR42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.1986.245","volume":"30","author":"WJ Welch","year":"1986","unstructured":"Welch WJ, Ott CE, Lorenz JN, Kotchen TA. Effects of chlorpropamide on loop of Henle function and plasma renin. Kidney Int 1986, 30: 712\u20136.","journal-title":"Kidney Int"},{"key":"BF03346668_CR43","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI111086","volume":"72","author":"E Kusano","year":"1983","unstructured":"Kusano E, Braun-Werness JL, Vick DJ, Keller MJ, Dousa TP. Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus. J Clin Invest 1983, 72: 1298\u2013313.","journal-title":"J Clin Invest"},{"key":"BF03346668_CR44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.289.6446.659","volume":"289","author":"AM Zalin","year":"1984","unstructured":"Zalin AM, Hutchinson CE, Jong M, Matthews K. Hyponatraemia during treatment with chlorpropamide and Moduretic (amiloride plus hydrochlorothiazide). Br Med J 1984, 289: 659.","journal-title":"Br Med J"},{"key":"BF03346668_CR45","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1152\/ajprenal.2000.279.1.F12","volume":"279","author":"MD Breyer","year":"2000","unstructured":"Breyer MD, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 2000, 279: F12\u201323.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BF03346668_CR46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9343(82)90452-1","volume":"72","author":"VL Szatalowicz","year":"1982","unstructured":"Szatalowicz VL, Goldberg JP, Anderson RJ. Plasma antidiuretic hormone in acute respiratory failure. Am J Med 1982, 72: 583\u20137.","journal-title":"Am J Med"},{"key":"BF03346668_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(90)90489-Z","volume":"88","author":"AR Hill","year":"1990","unstructured":"Hill AR, Uribarri J, Mann J, Berl T. Altered water metabolism in tuberculosis: role of vasopressin. Am J Med 1990, 88: 357\u201364.","journal-title":"Am J Med"},{"key":"BF03346668_CR48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.09-0405","volume":"137","author":"P Lee","year":"2010","unstructured":"Lee P, Ho KK. Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production. Chest 2010, 137: 207\u20138.","journal-title":"Chest"},{"key":"BF03346668_CR49","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0002-9343(86)90696-0","volume":"80","author":"GL Braden","year":"1986","unstructured":"Braden GL, Mikolich DJ, White CF, Germain MJ, Fitzgibbons JP. Syndrome of inappropriate antidiuresis in Waldenstr\u00f6m\u2019s macroglobulinemia. Am J Med 1986, 80: 1242\u20134.","journal-title":"Am J Med"},{"key":"BF03346668_CR50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s005200050284","volume":"8","author":"T Berghmans","year":"2000","unstructured":"Berghmans T, Paesmans M, Body JJ. A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer 2000, 8: 192\u20137.","journal-title":"Support Care Cancer"},{"key":"BF03346668_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jcem-59-3-505","volume":"59","author":"T Yamaji","year":"1984","unstructured":"Yamaji T, Ishibashi M, Hori T. Propressophysin in human blood: a possible marker of ectopic vasopressin production. J Clin Endocrinol Metab 1984, 59: 505\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346668_CR52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1001\/archinte.1986.00360210105016","volume":"146","author":"J Osterman","year":"1986","unstructured":"Osterman J, Calhoun A, Dunham M, et al. Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma. Evidence of ectopic production of arginine vasopressin by the tumor. Arch Intern Med 1986, 146: 1731\u20135.","journal-title":"Arch Intern Med"},{"key":"BF03346668_CR53","first-page":"322","volume":"27","author":"CD Flombaum","year":"2000","unstructured":"Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000, 27: 322\u201334.","journal-title":"Semin Oncol"},{"key":"BF03346668_CR54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s005200050284","volume":"8","author":"T Berghmans","year":"2000","unstructured":"Berghmans T, Paesmans M, Body JJ. A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer 2000, 8: 192\u20137.","journal-title":"Support Care Cancer"},{"key":"BF03346668_CR55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cncr.23542","volume":"113","author":"BI Gustafsson","year":"2008","unstructured":"Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer 2008, 113: 5\u201321.","journal-title":"Cancer"},{"key":"BF03346668_CR56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.emc.2005.03.001","volume":"23","author":"M Lin","year":"2005","unstructured":"Lin M, Liu SJ, Lim IT. Disorders of water imbalance. Emerg Med Clin North Am 2005, 23: 749\u201370.","journal-title":"Emerg Med Clin North Am"},{"key":"BF03346668_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3810\/pgm.2000.5.1.1068","volume":"107","author":"PJ Fall","year":"2000","unstructured":"Fall PJ. Hyponatremia and hypernatremia. Asystematic approach to causes and their correction. Postgrad Med 2000, 107: 75\u201382.","journal-title":"Postgrad Med"},{"key":"BF03346668_CR58","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S1357-2725(03)00139-0","volume":"35","author":"PH Baylis","year":"2003","unstructured":"Baylis PH. The syndrome of inappropiate antiuretic hormone secretion. Int J Biochem Cell Biol 2003, 35: 1495\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"BF03346668_CR59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00002512-199711010-00004","volume":"11","author":"TY Chan","year":"1997","unstructured":"Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging 1997, 11: 27\u201344.","journal-title":"Drugs Aging"},{"key":"BF03346668_CR60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.semnephrol.2009.03.004","volume":"29","author":"A Upadhyay","year":"2009","unstructured":"Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Semin Nephrol 2009, 29: 227\u201338.","journal-title":"Semin Nephrol"},{"key":"BF03346668_CR61","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2215\/CJN.04431007","volume":"3","author":"G Decaux","year":"2008","unstructured":"Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2008, 3: 1175\u201384.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BF03346668_CR62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/SMJ.0b013e31819b0e06","volume":"102","author":"EA Holm","year":"2009","unstructured":"Holm EA, Bie P, Ottesen M, \u00d8dum L, Jespersen B. Diagnosis of the syndrome of inappropriate secretion of antidiuretic hormone. South Med J 2009, 102: 380\u20134.","journal-title":"South Med J"},{"key":"BF03346668_CR63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/pgmj.2006.056515","volume":"83","author":"M Biswas","year":"2007","unstructured":"Biswas M, Davies JS. Hyponatremia in clinical practice. Postgrad Med J 2007, 83: 373\u20138.","journal-title":"Postgrad Med J"},{"key":"BF03346668_CR64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.revmed.2009.03.369","volume":"31","author":"A Passeron","year":"2010","unstructured":"Passeron A, Dupeux S, Blanchard A. Hyponatremia: from physiopathology to practice. Rev Med Interne 2010, 31: 277\u201386.","journal-title":"Rev Med Interne"},{"key":"BF03346668_CR65","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4158\/EP.12.4.446","volume":"12","author":"HM Siragy","year":"2006","unstructured":"Siragy HM. Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropiate antidiuretic hormone secretion: diagnosis and treatment options. Endocr Pract 2006, 12: 446\u201357.","journal-title":"Endocr Pract"},{"key":"BF03346668_CR66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0002-9343(88)90260-4","volume":"84","author":"E Cogan","year":"1988","unstructured":"Cogan E, Debieve MF, Pepersack T, Abramow M. Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. Am J Med 1988, 84: 409\u201318.","journal-title":"Am J Med"},{"key":"BF03346668_CR67","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2009.263","volume":"76","author":"JK Maesaka","year":"2009","unstructured":"Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting? Kidney Int 2009, 76: 934\u20138.","journal-title":"Kidney Int"},{"key":"BF03346668_CR68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0272-6386(98)70067-8","volume":"32","author":"JK Maesaka","year":"1998","unstructured":"Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis 1998, 32: 917\u201333.","journal-title":"Am J Kidney Dis"},{"key":"BF03346668_CR69","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1016\/S0272-6386(01)90005-8","volume":"37","author":"E Akalin","year":"2001","unstructured":"Akalin E, Chandrakantan A, Keane J, Hamburger RJ. Normouricemia in the syndrome of inappropriate antidiuretic hormone secretion. Am J Kidney Dis 2001, 37: E8.","journal-title":"Am J Kidney Dis"},{"key":"BF03346668_CR70","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1210\/jc.2008-0330","volume":"93","author":"W Fenske","year":"2008","unstructured":"Fenske W, St\u00f6rk S, Koschker AC, et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008, 93: 2991\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346668_CR71","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.1990.78","volume":"37","author":"T Berl","year":"1990","unstructured":"Berl T. Treating hyponatremia: damned if we do and damned if we don\u2019t. Kidney Int 1990, 37: 1006\u20138.","journal-title":"Kidney Int"},{"key":"BF03346668_CR72","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198606123142401","volume":"314","author":"AI Arieff","year":"1986","unstructured":"Arieff AI. Hyponatremia, convulsion, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986, 314: 1529\u201335.","journal-title":"N Engl J Med"},{"key":"BF03346668_CR73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-126-1-199701010-00008","volume":"126","author":"R Laureno","year":"1997","unstructured":"Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Int Med 1997, 126: 57\u201362.","journal-title":"Ann Int Med"},{"key":"BF03346668_CR74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ki.1989.9","volume":"35","author":"RH Sterns","year":"1989","unstructured":"Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after correction of hyponatremia. Kidney Int 1989, 35: 69\u201375.","journal-title":"Kidney Int"},{"key":"BF03346668_CR75","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(90)90517-H","volume":"88","author":"RH Sterns","year":"1990","unstructured":"Sterns RH. The treatment of hyponatremia: first, do no harm. Am J Med 1990, 88: 557\u201360.","journal-title":"Am J Med"},{"key":"BF03346668_CR76","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ki.1991.161","volume":"39","author":"JG Verbalis","year":"1991","unstructured":"Verbalis JG, Martinez AJ. Neurological and neurophatological sequelae of correction of chronic hyponatremia. Kidney Int 1991, 39: 1274\u201382.","journal-title":"Kidney Int"},{"key":"BF03346668_CR77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ncpendmet0459","volume":"4","author":"G Parenti","year":"2007","unstructured":"Parenti G, Ricca V, Zogheri A, Serio M, Mannelli M, Peri A. A case of hyponatremia caused by central hypocortisolism. Nat Clin Pract Endocrinol Metab 2007, 4: 369\u201375.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BF03346668_CR78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2265.2005.02318.x","volume":"63","author":"RM Reynolds","year":"2005","unstructured":"Reynolds RM, Seckl JR. Hyponatraemia for the clinical endocrinologists. Clin Endocrinol 2005, 63: 366\u201374.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"BF03346668_CR79","first-page":"S13","volume":"162","author":"CJ Thompson","year":"2010","unstructured":"Thompson CJ, Sherlock M. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol 2010, 162 (Suppl 1): S13\u20138.","journal-title":"Eur J Endocrinol"},{"key":"BF03346668_CR80","first-page":"338","volume-title":"Endocrinology and Metabolism","author":"GL Robertson","year":"1986","unstructured":"Robertson GL. Posterior pituitary. In: Felig P, Baxter JD, Broadus AE, Frohman LA eds. Endocrinology and Metabolism. 1st ed. New York: McGraw-Hill. 1986, 338\u201385.","edition":"1st"},{"issue":"1","key":"BF03346668_CR81","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","volume":"120","author":"JG Verbalis","year":"2007","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120 (Suppl 1): S1\u201321.","journal-title":"Am J Med"},{"key":"BF03346668_CR82","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1152\/ajpendo.00033.2004","volume":"287","author":"D Smith","year":"2004","unstructured":"Smith D, Moore K, Tormey W, Baylis PH, Thompson CJ. Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab 2004, 287: E1019\u201323.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF03346668_CR83","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1073\/pnas.0800001105","volume":"105","author":"J Nielsen","year":"2008","unstructured":"Nielsen J, Hoffert JD, Knepper MA, Agre P, Nielsen S, Fenton RA. Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci 2008, 105: 3634\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"BF03346668_CR84","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7326\/0003-4819-88-5-607","volume":"88","author":"PH Baylis","year":"1978","unstructured":"Baylis PH, Heath DA. Water disturbances in patients treated with oral lithium carbonate. Ann Int Med 1978, 88: 607\u20139.","journal-title":"Ann Int Med"},{"key":"BF03346668_CR85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ki.1986.80","volume":"29","author":"RG Walker","year":"1986","unstructured":"Walker RG, Escott M, Birchall I, Dowling JP, Kincaid-Smith P. Chronic progressive renal lesions induced by lithium. Kidney Int 1986, 29: 875\u201381.","journal-title":"Kidney Int"},{"key":"BF03346668_CR86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","volume":"5","author":"JP Grunfeld","year":"2009","unstructured":"Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009, 5: 270\u20136.","journal-title":"Nat Rev Nephrol"},{"key":"BF03346668_CR87","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/bmj.290.6484.1782","volume":"290","author":"G Decaux","year":"1985","unstructured":"Decaux G, Mols P, Cauchi P, Delwiche F. Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics. Br Med J (Clin Res Ed) 1985, 290: 1782\u20133.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BF03346668_CR88","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9343(01)00678-7","volume":"110","author":"G Decaux","year":"2001","unstructured":"Decaux G. Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med 2001, 110: 582\u20134.","journal-title":"Am J Med"},{"key":"BF03346668_CR89","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/ndt\/gfm138","volume":"22","author":"A Soupart","year":"2007","unstructured":"Soupart A, Schroeder B, Decaux G. Treatment of hyponatraemia by urea decreases risks of brain complications in rats. Brain osmolyte contents analysis. Nephrol Dial Transplant 2007, 22: 1856\u201363.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03346668_CR90","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/cs0770351","volume":"77","author":"R O Van","year":"1989","unstructured":"Van Reeth O, Decaux G. Rapid correction of hyponatraemia with urea may protect against brain damage in rats. Clin Sci 1989, 77: 351\u20135.","journal-title":"Clin Sci"},{"key":"BF03346668_CR91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(82)90825-7","volume":"72","author":"GL Robertson","year":"1982","unstructured":"Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982, 72: 339\u201353.","journal-title":"Am J Med"},{"key":"BF03346668_CR92","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1043-2760(03)00048-1","volume":"14","author":"BF Palmer","year":"2003","unstructured":"Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 2003, 14: 182\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"BF03346668_CR93","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1681\/ASN.V481522","volume":"4","author":"RH Sterns","year":"1994","unstructured":"Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994, 4: 1522\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346668_CR94","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1046\/j.1523-1755.2001.00063.x","volume":"60","author":"P Gross","year":"2001","unstructured":"Gross P. Treatment of severe hyponatremia. Kidney Int 2001, 60: 2417\u201327.","journal-title":"Kidney Int"},{"key":"BF03346668_CR95","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1681\/ASN.V10102165","volume":"10","author":"PY Martin","year":"1999","unstructured":"Martin PY, Abraham WT, Lieming X, et al. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol 1999, 10: 2165\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346668_CR96","doi-asserted-by":"crossref","first-page":"14B","DOI":"10.1016\/j.amjcard.2005.03.004","volume":"2","author":"SR Goldsmith","year":"2005","unstructured":"Goldsmith SR. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am J Cardiol 2005, 2: 14B\u201323B.","journal-title":"Am J Cardiol"},{"key":"BF03346668_CR97","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","volume":"104","author":"JE Udelson","year":"2001","unstructured":"Udelson JE, Smith WB, Hendrix GH, et al. Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation 2001, 104: 2417\u201323.","journal-title":"Circulation"},{"key":"BF03346668_CR98","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","volume":"91","author":"JK Ghali","year":"2006","unstructured":"Ghali JK, Koren MJ, Taylor JR, et al. Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 2006, 91: 2145\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346668_CR99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mlc.2001.119857","volume":"138","author":"G Decaux","year":"2001","unstructured":"Decaux G. Treatment of hyponatremic encephalopathy. J Lab Clin Med 2001, 138: 403.","journal-title":"J Lab Clin Med"},{"key":"BF03346668_CR100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","volume":"124","author":"AL Gerbes","year":"2003","unstructured":"Gerbes AL, G\u00fclberg V, Gin\u00e8s P, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003, 124: 933\u20139.","journal-title":"Gastroenterology"},{"key":"BF03346668_CR101","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","volume":"47","author":"WT Abraham","year":"2006","unstructured":"Abraham WT, Shamshirsaz AA, McFann K, Oren RM, Schrier RW. Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients. J Am Coll Cardiol 2006, 47: 1615\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"BF03346668_CR102","unstructured":"Biogen Idek and Cardiokine Partner to Develop Lixivaptan, a Novel Vasopressin Antagonist. 2007. Available at: http:\/www.reuters.com\/article\/pressRelease\/idUS162428+14-Feb-2008+BW20080214 ."},{"key":"BF03346668_CR103","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2215\/CJN.00160106","volume":"1","author":"A Soupart","year":"2006","unstructured":"Soupart A, Gross P, Legros JJ, et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol 2006, 1: 1154\u201360.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BF03346668_CR104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","volume":"48","author":"P Gin\u00e8s","year":"2008","unstructured":"Gin\u00e8s P, Wong F, Watson H, et al. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology 2008, 48: 204\u201313.","journal-title":"Hepatology"},{"key":"BF03346668_CR105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.amjcard.2005.10.050","volume":"97","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Gottlieb SS, Udelson JE, et al; Tolvaptan Investigators. Vasopressin V2 receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. Am J Cardiol 2006, 97: 1064\u20137.","journal-title":"Am J Cardiol"},{"key":"BF03346668_CR106","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FJC.0b013e318074f934","volume":"50","author":"SE Shoaf","year":"2007","unstructured":"Shoaf SE, Bramer SL, Bricmont P, Zimmer CA. Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide. J Cardiovasc Pharmacol 2007, 50: 213\u201322.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF03346668_CR107","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","volume":"355","author":"RW Schrier","year":"2006","unstructured":"Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Eng J Med 2006, 355: 2099\u2013112.","journal-title":"N Eng J Med"},{"key":"BF03346668_CR108","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297: 1319\u201331.","journal-title":"JAMA"},{"key":"BF03346668_CR109","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","volume":"21","author":"T Berl","year":"2010","unstructured":"Berl T, Quittnat-Pelletier F, Verbalis JG, et al; SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010, 21: 705\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346668_CR110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2010.01.013","volume":"56","author":"B Rozen-Zvi","year":"2010","unstructured":"Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L, Gafter U. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am J Kidney Dis 2010, 56: 325\u201337.","journal-title":"Am J Kidney Dis"},{"key":"BF03346668_CR111","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1359\/jbmr.090827","volume":"25","author":"JG Verbalis","year":"2010","unstructured":"Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res 2010, 25: 554\u201363.","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346668\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:19:16Z","timestamp":1648707556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":111,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BF03346668"],"URL":"https:\/\/doi.org\/10.1007\/bf03346668","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}